Population-level impact of isoniazid preventive therapy in South Africa

Location

Khayelitsha, South Africa, South Africa

Dates

08/01/2012 - 07/01/2015

PI

David Dowdy, MD, PhD, ScM

We are collaborating with a team that conducted a randomized trial of IPT in Khayelitsha, South Africa, to extend their findings and understand the potential population-level impact of IPT in this unique epidemiological setting.

Projects

Quantiferon gold test for detecting TB...

This is a cluster randomized trial comparing the time to known latent TB status among HIV infected patients receiving QGIT...

Read More

APT: Assessing PA-824 for Tuberculosis

A Phase 2 clinical trial of PA-824, an investigational nitroimidazole, as part of multidrug therapy for pulmonary TB; in...

Read More

TBM-KIDS (Malawi)

A phase 2 clinical trial of optimized treatment for pediatric tuberculous meningitis in India and Malawi

Read More